Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorHoly Family Hospital, Nazareth, Israel

About this trial

Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after delivery, which are particularly important during the critical period of mother-child bonding. Hemoglobin levels in the first 24 hours after delivery do not reflect the lowest point (nadir). The postpartum nadir occurs 48-72 hours after delivery due to the initial redistribution of plasma volume. The aim of this study was to examine whether postpartum ultrasound examination precedes laboratory test results in the diagnosis of anemia due to blood loss after cesarean section.

Eligibility criteria

Qualifiers

Women who delivered by a cesarean section.

Age over 18.

Fluent in Hebrew or Arabic.

Signed informed consent form.

Disqualifiers

Lack of consent or inability to provide informed consent.

Inability to perform a post-surgical ultrasound, such as post-surgery hospitalization in the intensive care unit.

Women with preoperative coagulation disorders.

Women whose clinical condition requires a post-cesarean ultrasound examination.

Trial design

Treatments tested in this trial

  • Ultrasound
  • Standard care

Treatment groups

276 Participants
are divided into 2 treatment groups